公开(公告)号：US20220016083A1

公开(公告)日：2022-01-20

申请号：US17295327

申请日：2019-11-21

Applicant: Foghorn Therapeutics Inc.

Inventor： Richard C. CENTORE ,  Lan XU ,  David LAHR

IPC: A61K31/4184 ,  A61K45/06 ,  A61K31/4439 ,  A61K31/496 ,  A61K31/5377 ,  A61P35/00

Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as melanoma, prostate cancer, breast cancer, bone cancer, renal cell carcinoma, and hematologic cancer.

公开(公告)号：US20220079940A1

公开(公告)日：2022-03-17

申请号：US17325937

申请日：2021-05-20

Applicant: Foghorn Therapeutics Inc.

Inventor： Richard C. CENTORE ,  Lan XU ,  David LAHR ,  Ammar ADAM

IPC: A61K31/501 ,  A61K45/06 ,  A61P35/04 ,  A61P35/02

Abstract: The present invention relates to methods and compositions for the treatment of BAF-related disorders such as acute myeloid leukemia.